Immunovant (IMVT) PT Raised to $32 at Goldman Sachs
Tweet
Share
E-mailGet Alerts IMVT Hot Sheet
Price: $39.90 -2.25%
Rating Summary:
16 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
16 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
Goldman Sachs analyst Corinne Johnson raised the price target on Immunovant (NASDAQ: IMVT) to $32.00 (from $29.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Designer Brands (DBI) PT Lowered to $6 at UBS
- Ultrapar Participacoes SA (UGPA3:BZ) (UGP) PT Raised to BRL39 at JPMorgan
- Science Applications (SAIC) PT Raised to $140 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
